Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial

Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial

Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL. Th...

Full description

Saved in:
Bibliographic Details
Main Authors: Matteo Pagnesi, Gad Cotter, Beth A. Davison, Yonathan Freund, Adriaan A. Voors, Christopher Edwards, Maria Novosadova, Koji Takagi, Hamlet Hayrapetyan, Andranik Mshetsyan, Mayranush Drambyan, Alain Cohen‐Solal, Jozine M. terMaaten, Jan Biegus, Piotr Ponikowski, Gerasimos Filippatos, Ovidiu Chioncel, Malha Sadoune, Tabassome Simon, Douglas L. Mann, Alexandre Mebazaa, Marco Metra
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:ESC Heart Failure
Subjects:
acute heart failure
corticosteroids
EQ‐5D‐5L
EQ‐VAS
inflammation
quality of life
Online Access:https://doi.org/10.1002/ehf2.15235
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ehf2.15235

Similar Items